Suchergebnisse - (Person:"Liu, Binliang")

PubPharm (3)

1

Exploring the clinical outcomes and safety profile of inetetamab treatment in metastatic breast cancer patients : A multicenter assessment of a Chinese-origin recombinant Anti-HER2 monoclonal antibody

enthalten in: Breast (Edinburgh, Scotland) | 2023

von Liu, B. | Xie, N. | Tian, C. | +16

2

Focus on anticancer therapy-induced cardiotoxicity from the perspective of oncologists

enthalten in: Chinese medical journal | 2022

von Liu, B. | Wang, Y. | Lyu, D. | +1

3

Antibody-drug conjugates in HER2-positive breast cancer

enthalten in: Chinese medical journal | 2021

von Li, L. | Zhang, D. | Liu, B. | +5

1
[1]